Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    March 2019
  1. PINTO G, Tondi L, Gemma M, De Marco A, et al
    Real Life Indications to Sacubitril/Valsartan Treatment in Patients with Chronic Systolic Heart Failure.
    J Cardiovasc Pharmacol. 2019 Mar 6. doi: 10.1097/FJC.0000000000000665.
    PubMed     Text format     Abstract available


    December 2018
  2. DU AX, Westerhout CM, McAlister FA, Shanks M, et al
    The Titration and Tolerability of Sacubitril/Valsartan for Patients with Heart Failure in Clinical Practice.
    J Cardiovasc Pharmacol. 2018 Dec 10. doi: 10.1097/FJC.0000000000000643.
    PubMed     Text format     Abstract available


    November 2018
  3. LEENEN FH, Ahmad M, Marc Y, Llorens-Cortes C, et al
    Specific Inhibition of Brain Angiotensin III formation as a new strategy for prevention of heart failure after myocardial infarction.
    J Cardiovasc Pharmacol. 2018 Nov 30. doi: 10.1097/FJC.0000000000000638.
    PubMed     Text format     Abstract available


    May 2018
  4. VERRIER RL
    Ivabradine's Pleiotropic Profile: Can It Protect against Doxorubicin-Induced Heart Failure?
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000597.
    PubMed     Text format    


  5. CHANG PC, Lu YY, Lee HL, Lin SF, et al
    Paradoxical Effects of Sodium-Calcium Exchanger Inhibition on Torsade de Pointes and Early Afterdepolarization in a Heart Failure Rabbit Model.
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000598.
    PubMed     Text format     Abstract available


    April 2018
  6. SALAH EM, Bastacky SI, Jackson EK, Tofovic SP, et al
    Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    J Cardiovasc Pharmacol. 2018;71:205-214.
    PubMed     Text format     Abstract available


    November 2017
  7. COLE-JEFFREY CT, Pepine CJ, Katovich MJ, Grant MB, et al
    Beneficial Effects Of Angiotensin-(1-7) On Cd34 + Cells From Heart Failure Patients.
    J Cardiovasc Pharmacol. 2017 Nov 8. doi: 10.1097/FJC.0000000000000556.
    PubMed     Text format     Abstract available


    September 2017
  8. ABBATE A, Van Tassell BW
    Levosimendan in advanced heart failure: where do we stand?
    J Cardiovasc Pharmacol. 2017 Sep 25. doi: 10.1097/FJC.0000000000000539.
    PubMed     Text format    


    August 2017
  9. ALTENBERGER J, Gustafsson F, Harjola VP, Karason K, et al
    Levosimendan in acute and advanced heart failure: an appraisal of the clinical database and evaluation of its therapeutic applications.
    J Cardiovasc Pharmacol. 2017 Aug 15. doi: 10.1097/FJC.0000000000000533.
    PubMed     Text format     Abstract available


    June 2017
  10. HANSEN MS, Andersen A, Holmboe S, Schultz JG, et al
    Levosimendan prevents and reverts right ventricular failure in experimental pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2017 Jun 19. doi: 10.1097/FJC.0000000000000508.
    PubMed     Text format     Abstract available


    April 2017
  11. BEI WJ, Wang K, Li HL, Lin KY, et al
    Safe Hydration Volume to Prevent Contrast-Induced Acute Kidney Injury and Worsening Heart Failure in Patients with Heart Failure and Preserved Ejection Fraction Following Cardiac Catheterization.
    J Cardiovasc Pharmacol. 2017 Apr 27. doi: 10.1097/FJC.0000000000000502.
    PubMed     Text format     Abstract available


    February 2017
  12. KOLPAKOV MA, Tilley DG, Sabri A
    Galphaq Signaling in the Regulation of Autophagy and Heart Failure.
    J Cardiovasc Pharmacol. 2017 Feb 3. doi: 10.1097/FJC.0000000000000471.
    PubMed     Text format    


  13. HU J, Sharifi-Sanjani M, Tofovic SP
    Nitrite Prevents Right Ventricular Failure and Remodeling Induced by Pulmonary Artery Banding.
    J Cardiovasc Pharmacol. 2017;69:93-100.
    PubMed     Text format     Abstract available


    January 2017
  14. HOLMBOE S, Andersen A, Johnsen J, Nielsen JM, et al
    Inotropic Effects of Prostacyclins on the Right Ventricle Are Abolished in Isolated Rat Hearts With Right-Ventricular Hypertrophy and Failure.
    J Cardiovasc Pharmacol. 2017;69:1-12.
    PubMed     Text format     Abstract available


    April 2016
  15. HILLGAARD TK, Andersen A, Andersen S, Vildbrad MD, et al
    Levosimendan Prevents Pressure-Overload-induced Right Ventricular Failure.
    J Cardiovasc Pharmacol. 2016;67:275-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: